Faster test could curb powerful antibiotic overuse in critically ill patients
NCT ID NCT07267624
Summary
This study aims to see if using a faster, more detailed lab test on lung fluid samples can help doctors in intensive care units (ICUs) reduce the use of powerful, broad-spectrum antibiotics for patients with ventilator-associated pneumonia. It will compare this new testing approach to standard methods in about 170 critically ill adults. The main goal is to see if patients can spend fewer hours on these strong antibiotics in their first week, which could help fight antibiotic resistance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTENSIVE CARE (ICU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dept. of Intensive Care Medicine, University hospital of Lausanne
Lausanne, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Division of Intensive care, Hospital of Lugano
Lugano, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Division of Intensive care, Hospital of Neuchâtel
Neuchâtel, Switzerland
Contact Phone: •••-•••-••••
Contact
-
Division of Intensive care, University hospital of Sion
Sion, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
University hospitals of Geneva, Division of Intensive Care
Geneva, Canton of Geneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.